QA: Notable Labs Ltd in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001603207_2023_Notable_Labs_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001603207, Notable Labs Ltd

  xvar xval
0 AssetsCurrent 22,149,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,601,000
3 remainder_Assets 909,000
4 LiabilitiesCurrent 6,731,000
5 LiabilitiesNoncurrent 477,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 104,000
8 SellingGeneralAndAdministrativeExpense 11,754,000
9 ResearchAndDevelopmentExpense 21,653,000
10 remainder_Expenses 0
11 remainder_Revenues 658,000
12 remainder_NetIncome 549,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 29,659,000
1 Liabilities 7,208,000
2 Expenses 33,511,000
3 Revenues 658,000
4 StockholdersEquity 22,451,000
5 NetIncome -32,304,000
6 ComprehensiveNetIncome -32,304,000
7 BaseVar 35,792,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.903
9 EconomicCapitalRatio 2.22

Edgar->Model Mapping

Feature Distribution